Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2011, Article ID 217896, 11 pages
http://dx.doi.org/10.1155/2011/217896
Research Article

Plasminogen Activator Inhibitor-Type I Gene Deficient Mice Show Reduced Influx of Neutrophils in Ventilator-Induced Lung Injury

1Department of Anesthesiology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
2Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
3Department of Internal Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
4Department of Pathology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
5Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
6Department of Intensive Care Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
7HERMES Critical Care Group, Amsterdam, The Netherlands

Received 28 February 2011; Revised 15 May 2011; Accepted 17 May 2011

Academic Editor: Peter J. Papadakos

Copyright © 2011 Esther K. Wolthuis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Günther, P. Mosavi, S. Heinemann et al., “Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome,” The American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 2 I, pp. 454–462, 2000. View at Google Scholar · View at Scopus
  2. M. J. Schultz, J. Millo, M. Levi et al., “Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia,” Thorax, vol. 59, no. 2, pp. 130–135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Sapru, H. Hansen, T. Ajayi et al., “4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia,” Anesthesiology, vol. 110, no. 5, pp. 1086–1091, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. Y. Song, S. V. Lynch, J. Flanagan et al., “Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa,” Anesthesiology, vol. 106, no. 2, pp. 252–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. L. B. Ware, M. A. Matthay, P. E. Parsons et al., “Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome,” Critical Care Medicine, vol. 35, no. 8, pp. 1821–1828, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. G. B. Allen, T. Leclair, M. Cloutier, J. Thompson-Figueroa, and J. H. Bates, “The response to recruitment worsens with progression of lung injury and fibrin accumulation in a mouse model of acid aspiration,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 292, no. 6, pp. L1580–L1589, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. P. G. Arndt, S. K. Young, and G. S. Worthen, “Regulation of lipopolysaccharide-induced lung inflammation by plasminogen activator inhibitor-1 through a JNK-mediated pathway,” Journal of Immunology, vol. 175, no. 6, pp. 4049–4059, 2005. View at Google Scholar · View at Scopus
  8. C. Barazzone, D. Belin, P. F. Piguet, J. D. Vassalli, and A. P. Sappino, “Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury,” Journal of Clinical Investigation, vol. 98, no. 12, pp. 2666–2673, 1996. View at Google Scholar · View at Scopus
  9. G. S. Worthen, C. Haslett, A. J. Rees, R. S. Gumbay, J. E. Henson, and P. M. Henson, “Neutrophil-mediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung,” The American Review of Respiratory Disease, vol. 136, no. 1, pp. 19–28, 1987. View at Google Scholar · View at Scopus
  10. E. Abraham, A. Carmody, R. Shenkar, and J. Arcaroli, “Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 279, no. 6, pp. L1137–L1145, 2000. View at Google Scholar · View at Scopus
  11. D. M. Shasby, K. M. Vanbenthuysen, R. M. Tate, S. S. Shasby, I. McMurtry, and J. E. Repine, “Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals,” The American Review of Respiratory Disease, vol. 125, no. 4, pp. 443–447, 1982. View at Google Scholar · View at Scopus
  12. R. L. Zemans, S. P. Colgan, and G. P. Downey, “Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury,” The American Journal of Respiratory Cell and Molecular Biology, vol. 40, no. 5, pp. 519–535, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. R. Gyetko, S. Sud, T. Kendall, J. A. Fuller, M. W. Newstead, and T. J. Standiford, “Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection,” Journal of Immunology, vol. 165, no. 3, pp. 1513–1519, 2000. View at Google Scholar · View at Scopus
  14. A. W. Rijneveld, M. Levi, S. Florquin, P. Speelman, P. Carmeliet, and T. van der Poll, “Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia,” Journal of Immunology, vol. 168, no. 7, pp. 3507–3511, 2002. View at Google Scholar · View at Scopus
  15. P. Carmeliet and D. Collen, “Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system,” Thrombosis Research, vol. 91, no. 6, pp. 255–285, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. J. D. Vassalli, A. P. Sappino, and D. Belin, “The plasminogen activator/plasmin system,” Journal of Clinical Investigation, vol. 88, no. 4, pp. 1067–1072, 1991. View at Google Scholar · View at Scopus
  17. W. Kuhn, L. Pache, B. Schmalfeldt et al., “Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy,” Gynecologic Oncology, vol. 55, no. 3 I, pp. 401–409, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. A. Noël, V. Albert, K. Bajou et al., “New functions of stromal proteases and their inhibitors in tumor progression,” Surgical Oncology Clinics of North America, vol. 10, no. 2, pp. 417–432, 2001. View at Google Scholar · View at Scopus
  19. H. Pedersen, N. Brunner, D. Francis et al., “Prognostic impact of urokinase, urokinase receptor and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue,” Cancer Research, vol. 54, no. 17, pp. 4671–4675, 1994. View at Google Scholar · View at Scopus
  20. G. Choi, E. K. Wolthuis, P. Bresser et al., “Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury,” Anesthesiology, vol. 105, no. 4, pp. 689–695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Dahlem, A. P. Bos, J. J. Haitsma, M. J. Schultz, J. C. Meijers, and B. Lachmann, “Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation,” Intensive Care Medicine, vol. 31, no. 5, pp. 724–732, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. P. Dahlem, A. P. Bos, J. J. Haitsma et al., “Mechanical ventilation affects alveolar fibrinolysis in LPS-induced lung injury,” The European Respiratory Journal, vol. 28, no. 5, pp. 992–998, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. A. Belperio, M. P. Keane, M. D. Burdick et al., “Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury,” Journal of Clinical Investigation, vol. 110, no. 11, pp. 1703–1716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Imanaka, M. Shimaoka, N. Matsuura, M. Nishimura, N. Ohta, and H. Kiyono, “Ventilator-induced lung injury is associated with neutrophil infiltration, macrophage activation, and TGF-beta 1 mRNA upregulation in rat lungs,” Anesthesia and Analgesia, vol. 92, no. 2, pp. 428–436, 2001. View at Google Scholar · View at Scopus
  25. P. C. Rimensberger, L. Fedorko, E. Cutz, and D. J. Bohn, “Attenuation of ventilator-induced acute lung injury in an animal model by inhibition of neutrophil adhesion by leumedins (NPC 15669),” Critical Care Medicine, vol. 26, no. 3, pp. 548–555, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Carmeliet, J. M. Stassen, L. Schoonjans et al., “Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis and thrombolysis,” Journal of Clinical Investigation, vol. 92, no. 6, pp. 2756–2760, 1993. View at Google Scholar · View at Scopus
  27. E. K. Wolthuis, A. P. Vlaar, G. Choi, J. J. Roelofs, N. P. Juffermans, and M. J. Schultz, “Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice,” Critical Care, vol. 13, no. 1, p. R1, 2009. View at Google Scholar · View at Scopus
  28. R. Renckens, J. J. Roelofs, P. I. Bonta et al., “Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia,” Blood, vol. 109, no. 4, pp. 1593–1601, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. J. J. Roelofs, G. J. Teske, P. I. Bonta et al., “Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis,” Kidney International, vol. 75, no. 1, pp. 52–59, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. D. W. Sommeijer, R. van Oerle, P. H. Reitsma et al., “Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes,” Thrombosis Journal, vol. 3, article 12, 2005. View at Publisher · View at Google Scholar · View at PubMed
  31. P. Carmeliet, L. Moons, R. Lijnen et al., “Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice,” Circulation, vol. 96, no. 9, pp. 3180–3191, 1997. View at Google Scholar · View at Scopus
  32. V. De Waard, E. K. Arkenbout, P. Carmeliet, V. Lindner, and H. Pannekoek, “Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model,” Arteriosclerosis, Thrombosis and Vascular Biology, vol. 22, no. 12, pp. 1978–1983, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Levi, E. de Jonge, and T. van der Poll, “Sepsis and disseminated intravascular coagulation,” Journal of Thrombosis and Thrombolysis, vol. 16, no. 1-2, pp. 43–47, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. J. P. Chen, D. W. Rowe, and B. L. Enderson, “Contrasting post-traumatic serial changes for D-dimer and PAI-1 in critically injured patients,” Thrombosis Research, vol. 94, no. 3, pp. 175–185, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Y. Liu, S. K. Liao, C. C. Huang, Y. H. Tsai, D. A. Quinn, and L. F. Li, “Role for nuclear factor-kappaB in augmented lung injury because of interaction between hyperoxia and high stretch ventilation,” Translational Research, vol. 154, no. 5, pp. 228–240, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. S. Choudhury, M. R. Wilson, M. E. Goddard, K. P. O'Dea, and M. Takata, “Mechanisms of early pulmonary neutrophil sequestration in ventilator-induced lung injury in mice,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 287, no. 5, pp. L902–L910, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. E. K. Wolthuis, A. P. Vlaar, G. Choi et al., “Recombinant human soluble tumor necrosis factor-alpha receptor fusion protein partly attenuates ventilator-induced lung injury,” Shock, vol. 31, no. 3, pp. 262–266, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. D. T. Eitzman, R. D. McCoy, X. Zheng et al., “Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene,” Journal of Clinical Investigation, vol. 97, no. 1, pp. 232–237, 1996. View at Google Scholar · View at Scopus
  39. K. Van Ness, V. Chobaz-Péclat, M. Castellucci, A. So, and N. Busso, “Plasminogen activator inhibitor type-1 deficiency attenuates murine antigen-induced arthritis,” Rheumatology, vol. 41, no. 2, pp. 136–141, 2002. View at Google Scholar · View at Scopus
  40. A. R. Kitching, Y. Z. Kong, X. R. Huang et al., “Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis,” Journal of the American Society of Nephrology, vol. 14, no. 6, pp. 1487–1495, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. Hegeman, M. P. Hennus, C. J. Heijnen et al., “Ventilator-induced endothelial activation and inflammation in the lung and distal organs,” Critical Care, vol. 13, no. 6, p. R182, 2009. View at Google Scholar · View at Scopus
  42. “Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network,” The New England Journal of Medicine, vol. 342, no. 18, pp. 1301–1308, 2000.
  43. V. M. Ranieri, F. Giunta, P. M. Suter, and A. S. Slutsky, “Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome,” Journal of the American Medical Association, vol. 284, no. 1, pp. 43–44, 2000. View at Google Scholar · View at Scopus
  44. P. G. Arndt, S. K. Young, K. R. Poch et al., “Systemic inhibition of the angiotensin-converting enzyme limits lipopolysaccharide-induced lung neutrophil recruitment through both bradykinin and angiotensin II-regulated pathways,” Journal of Immunology, vol. 177, no. 10, pp. 7233–7241, 2006. View at Google Scholar · View at Scopus
  45. L. B. Ware and M. A. Matthay, “The acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 342, no. 18, pp. 1334–1349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Sakashita, Y. Nishimura, T. Nishiuma et al., “Neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury in mice,” The European Journal of Pharmacology, vol. 571, no. 1, pp. 62–71, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. J. H. Kim, M. H. Suk, D. W. Yoon et al., “Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 291, no. 4, pp. L580–L587, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. A. A. El-Solh, M. Okada, C. Pietrantoni, A. Aquilina, and E. Berbary, “Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: impact of inadequate antimicrobial therapy,” Intensive Care Medicine, vol. 30, no. 10, pp. 1914–1920, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus